Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00576927Phase 4Completed
Phase 4, randomised, double-blind trial in Insomnia comparing Ramelteon + SHI with Placebo + SHI (2 arms). Primary endpoint: Number of Participants Meeting Good Sleep Latency Criteria at 1 week. Started Oct 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00576927.